Skip to main content
. 2022 Jan 7;17(8):1809–1813. doi: 10.4103/1673-5374.332155

Figure 3.

Figure 3

Changes in neurological function scores of acute stroke patients over the year after ta-VNS treatment.

(A–E) WMFT score, WMFT time, FMA-U, FMA-L, and FMA-S. Data are expressed as mean ± SD (n = 28). *P < 0.05, vs. control group (repeated-measures analysis of variance). FMA-L: Fugl-Meyer assessment–lower extremity; FMA-S: Fugl-Meyer assessment–sensory; FMA-U: Fugl-Meyer assessment–upper extremity; WMFT: Wolf Motor Function Test.